跳至主要内容
临床试验/CTRI/2023/07/055621
CTRI/2023/07/055621尚未招募Unknown

PRE-EMPTIVE USE OF ORAL TIZANIDINE IN LAPAROSCOPIC ABDOMINAL SURGERIES : A PROSPECTIVE RANDOMIZED PLACEBO CONTROLLED DOUBLE BLIND STUDY - nil

Fortis Escorts Hospital Faridabad0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
Unknown
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.Age 18-60 years
  • 2.ASA status I and II
  • 3.BMI less than 35

排除标准

  • 1. ASA status more than II
  • 2.BMI more than 35
  • 3. Laparoscopic hernia repair surgeries
  • 4.Emergency cases
  • 5. Allergy to tizanidine
  • 6. History of alcohol consumption
  • 7. Patients on treatment with beta-blockers, digoxin, anticonvulsants, antihypertensive drugs, sedatives or α2 agonists
  • 8. CNS disorders
  • 9. Renal or hepatic insufficiency
  • 10. Peptic ulcer
  • 11. Hypertension
  • 12. Patients with chronic pain
  • 13. Bleeding disorders
  • 14. Sleep disturbances

研究者

发起方
Fortis Escorts Hospital Faridabad

相似试验